The use of current knowledge and non‐invasive testing modalities for predicting at‐risk non‐alcoholic steatohepatitis and assessing fibrosis

A sequential approach using the age‐adjusted fibrosis‐4 index and vibration‐controlled transient elastography to detect advanced fibrosis in Korean patients with non‐alcoholic fatty liver disease

(2022) Dong Hyeon Lee et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events

(2022) Jerome Boursier et al.   JOURNAL OF HEPATOLOGY

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

(2022) Kenneth Cusi et al.   Endocrine Practice

Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease?

(2022) Zobair M. Younossi et al.   HEPATOLOGY

Greater ectopic fat deposition and liver fibroinflammation, and lower skeletal muscle mass in people with type 2 diabetes

(2022) Tom Waddell et al.   Obesity

AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review

(2022) Michelle T. Long et al.   GASTROENTEROLOGY

Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants

(2022) Veeral Ajmera et al.   GASTROENTEROLOGY

Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort

(2021) Kento Imajo et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis

(2021) Andrea Dennis et al.   Frontiers in Endocrinology

Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

(2021) Stephen A. Harrison et al.   JOURNAL OF HEPATOLOGY

Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis

(2021) Helena B. Thomaides-Brears et al.   DIGESTIVE DISEASES AND SCIENCES

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease

(2021) Fasiha Kanwal et al.   GASTROENTEROLOGY

Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity

(2021) Andreas Drolz et al.   INTERNATIONAL JOURNAL OF OBESITY

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

(2021) Annalisa Berzigotti et al.   JOURNAL OF HEPATOLOGY

Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease

(2021) Zobair M. Younossi et al.   JAMA Network Open

Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis

(2021) Anneli Andersson et al.   Clinical Gastroenterology and Hepatology

Comparison of diagnostic performance between FIB‐4 and NFS in metabolic‐associated fatty liver disease era

(2021) Huiyul Park et al.   HEPATOLOGY RESEARCH

MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis

(2021) Mazen Noureddin et al.   JOURNAL OF HEPATOLOGY

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

(2021) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease

(2020) Tasnim Alkayyali et al.   ACTA DIABETOLOGICA

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

(2020) Philip N Newsome et al.   Lancet Gastroenterology & Hepatology

Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease

(2020) Amandeep Singh et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices

(2020) Zobair M. Younossi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease

(2020) Arjun N.A. Jayaswal et al.   LIVER INTERNATIONAL

MR elastography‐based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study

(2020) Ma Ai Thanda Han et al.   LIVER INTERNATIONAL

A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study

(2020) Stephen A Harrison et al.   Lancet Gastroenterology & Hepatology

Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation and Death in NAFLD

(2020) Tolga Gidener et al.   Clinical Gastroenterology and Hepatology

Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index

(2020) Fatih Eren et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes

(2020) Zobair M. Younossi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

(2019) Arun J. Sanyal et al.   HEPATOLOGY

Past, present and future perspectives in nonalcoholic fatty liver disease

(2019) Arun J. Sanyal   Nature Reviews Gastroenterology & Hepatology

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease

(2019) Eda Kaya et al.   Gut and Liver

The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis

(2019) Fuad Jafarov et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients

(2019) Stuart Gordon et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances

(2018) Mazen Noureddin et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The enhanced liver fibrosis (ELF) test in diagnosis and management of liver fibrosis

(2018) James W Day et al.   BRITISH JOURNAL OF HOSPITAL MEDICINE

The role of 3D-MRE in the diagnosis of NASH in obese patients undergoing bariatric surgery

(2018) Alina M. Allen et al.   HEPATOLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

(2017) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity

(2017) Michael Pavlides et al.   LIVER INTERNATIONAL

Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage

(2017) Mario Masarone et al.   PLoS One

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

(2016) Stuart McPherson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

(2016) Vlad Ratziu et al.   GASTROENTEROLOGY

Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort

(2016) Veronica Wendy Setiawan et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging

(2016) Laurence Blake et al.   BMJ Open

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

(2015) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma

(2015) Mazen Noureddin et al.   Clinics in Liver Disease

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

(2015) Robert J. Wong et al.   GASTROENTEROLOGY

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis

(2015) Bashar Mohamad et al.   Hepatology International

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD

(2012) Z. Permutt et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality

(2011) Zobair M. Younossi et al.   HEPATOLOGY

T1 independent, T2* corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis

(2011) Catherine D.G. Hines et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING